Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Flexibility and well considered manufacturing approaches could help tablet manufacturers face the increasing pressure resulting from the shifting bio/pharma development landscape.


Under Pressure

Kelly Boyer is general manager, Film Coatings at Colorcon Inc.

Market demand and regulatory guidance continues to promote improved medication design.


Gilding the Pill

JÃ©rÃ´me Revel is senior development engineer at Recipharm.

Philippe Gorria is senior director of Pharmaceutical Development at Recipharm.

Modified-release oral dosage forms can offer benefits to both formulation scientists and patients.

Modified-Release Formulations: Improving Efficacy and Patient Compliance

Valitacell, Solentim, and Microcoat were awarded EUR 3.5 million (US$4 million) to produce an integrated platform to deposit, culture, profile, and select optimal cells for biologic drug manufacturing.

Valitacell, Solentim Funded for Biologics and Cell Therapy Development

Researchers at the Georgia Institute of Technology developed a technique for administering contraceptive hormones through ‘pharmaceutical jewelry’. 

Pharmaceutical Jewelry Could Offer a New Family Planning Approach

Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.

Catalent Invests in Zydis Ultra Commercialization

Janssen’s Spravato (esketamine) gains approval with restricted distribution guidelines.

FDA Approves New Treatment for Depression

Hetero Labs recalls losartan potassium tablets due to presence of N-Nitroso-N-methyl-4-aminobutyric acid.

Latest ARB Recall Triggered by New Impurity

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.


Strategic Screening for Solubility Solutions

Michael Avraam is global product manager at ChargePoint Technology for the PharmaSafe range of products.

Containment valves and smart monitoring can keep employees safe and improve manufacturing efficiency when handling potent APIs, intermediates, and solid-dosage drugs.